Praxis Precision Medicines general counsel sells $4.8m in shares
Director Amy DuRoss of BIOLIFE SOLUTIONS INC (NASDAQ:BLFS) recently sold 6,000 shares of common stock for approximately $148,545, in a series of transactions.
According to a Form 4 filing with the Securities and Exchange Commission, the sales occurred between November 19 and November 21, 2025.
On November 19, DuRoss sold 477 shares at a price of $24.50 per share. The following day, November 20, she sold 4,523 shares at $24.51 per share. On November 21, DuRoss sold 1,000 shares at $26.00 per share.
Following these transactions, DuRoss directly owns 24,687 shares of BioLife Solutions.
In other recent news, BioLife Solutions reported its Q3 2025 earnings, showcasing a notable performance. The company achieved revenue of $28.1 million, which exceeded the forecast of $25.69 million. Additionally, BioLife Solutions reported earnings per share of $0.01, outperforming the anticipated loss of $0.01. This represented a 200% surprise compared to analyst expectations. Despite these positive financial results, the stock price experienced a decline in aftermarket trading. These developments reflect the company’s current financial trajectory and market reactions. Investors and analysts will likely continue to monitor BioLife Solutions’ performance closely.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.